Trial Profile
KD-404 Phase I/II Study
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 08 Sep 2022
Price :
$35
*
At a glance
- Drugs KD 404 (Primary) ; Influenza virus vaccine
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors KM Biologics
- 08 Sep 2022 Status changed from recruiting to completed.
- 05 Nov 2018 New trial record